How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test evaluates predispositions in key metabolic pathwaysincluding GIPR rs1800437, and MC4R rs17782313 variantsthat may influence how individual patients respond to GLP-1 therapy and weight regulation
doi: 10.3389/fpsyt.2021.669089 Received 17 February 2021 Accepted 16 August 2021 Published 30 September 2021 Volume 12 - 2021 Edited by Francesca Bonomini, University of Brescia, Italy Reviewed by Mostafa Waly, Sultan Qaboos University, Oman
Weight Loss Assistance While the simple addition of B12 will not burn off the pounds while people sit on the couch, the addition of B12 to proper diet and exercise can help accelerate weight loss
The 2022 FDA compounding restriction eliminated the previously available pathway through compounding pharmacies, narrowing the legal access routes further
Canadian researchers report consistent improvements in grip strength, pain reduction, and range of motion within the first 2-3 weeks of use
The rapid advancement of genomic sequencing technologies has opened new frontiers in medical research